Citation: | PEI Jianghong, XIAO Yu, Li Qixing, ZHAO Zihao, CHEN Li. Synthesis and antitumor activity of novel CDDO derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(5): 548-553. DOI: 10.11665/j.issn.1000-5048.20170507 |
[1] |
Pollier J,Goossens A.Oleanolic acid[J].Phytochemistry,2012,77(5):10-15.
|
[2] |
Sporn MB,Liby KT,Yore MM,et al.New synthetic triterpenoids:potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress[J].J Nat Prod,2011,74(3):537-545.
|
[3] |
Liby KT,Sporn MB.Synthetic oleanane triterpenoids:multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease[J].Pharmacol Rev,2012,64(4):972-1003.
|
[4] |
Liby KT, Yore MM, Sporn MB. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer[J].Nat Rev Cancer,2007,7(5):357-369.
|
[5] |
Liby K,Yore MM,Roebuck BD,et al.A novel acetylenic tricyclic bis-(cyano enone)potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin[J].Cancer Res,2008,68(16):6727-6733.
|
[6] |
Hong DS,Kurzrock R,Supko JG,et al.A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas[J].Clin Cancer Res,2012,18(12):3396-3406.
|
[7] |
Pergola PE,Raskin P,Toto RD,et al.Bardoxolone methyl and kidney function in CKD with type 2 diabetes[J].N Engl J Med,2011,365(4):327-336.
|
[8] |
Chartoumpekis DV, Sykiotis GP. Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease[J].N Engl J Med,2014,370(18):1767-1769.
|
[9] |
de Zeeuw D,Akizawa T,Audhya P,et al.Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease[J].N Engl J Med,2013,369(26):2492-2503.
|
[10] |
Taylor RD,MacCoss M,Lawson ADG.Rings in drugs[J].J Med Chem,2014,57(14):5845-5859.
|
[11] |
Xiao Y,Luo QF,Li QX,et al.Improved synthesis of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid[J].Chin J Med Chem(中国药物化学杂志),2016,26(2):131-135.
|
[12] |
Liu Y,Wang TT,Chen L.Synthesis and antitumor activity of isosteviol derivatives[J].J China Pharm Univ(中国药科大学学报),2016,47(1):48-53.
|